Side-by-side comparison of AI visibility scores, market position, and capabilities
Beaverton global athletic footwear and apparel (NYSE: NKE) at $51.4B FY2024 revenue with 18% market share; CEO Elliott Hill returned Sept 2024 with Win Now strategy to restore wholesale channels and running category competing with On Running and adidas.
Nike, Inc. is a Beaverton, Oregon-based global athletic footwear, apparel, and equipment company — publicly traded on the New York Stock Exchange (NYSE: NKE) as a Dow Jones Industrial Average and S&P 500 component — generating $51.4 billion in fiscal year 2024 (ended May 31, 2024) revenue with approximately 83,700 employees worldwide and approximately 18% global athletic footwear market share. Nike brands include Nike (performance footwear, apparel, and equipment), Jordan Brand (lifestyle basketball and athletic), and Converse (lifestyle footwear). In September 2024, Elliott Hill returned to Nike as President and CEO (replacing John Donahoe who had led the company since 2020), launching a "Win Now" strategy focused on sport performance product investment, wholesale partner relationship restoration, and competitive positioning in running and basketball categories. Nike Direct (direct-to-consumer e-commerce and owned stores) generated 44% of FY2024 revenue. Nike was founded in 1964 as Blue Ribbon Sports by Phil Knight and Bill Bowerman; renamed Nike in 1978 with IPO in 1980.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.